Trials / Not Yet Recruiting

Not Yet RecruitingNCT06584747

Study of Cerebral Vascular Reserve Using Pharmacological Testing With Acetazolamide: A Non-Inferiority Study of PET Method Compared to Conventional Reference Scintigraphy

Status: Not Yet Recruiting
Phase: N/A
Study type: Interventional
Enrollment: 22 (estimated)

Sponsor: Centre Antoine Lacassagne · Academic / Other
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

This study compares two methods for assessing brain blood flow. PET scan will be use with a drug called Acetazolamide and compare its effectiveness to the standard scintigraphy method. The goal is to see if the PET scan is just as good as the traditional method in measuring how well the brain's blood vessels respond to the drug.

Conditions

Cerebrovascular Circulation

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	PET scan	18F-FDG PET scans will be performed to assess cerebral vascular reserve. For exams involving stimulation with Acetazolamide (DIAMOX®), the radiopharmaceutical injection (18F-FDG or 99mTc-HMPAO) will start exactly 15 minutes after the Acetazolamide (DIAMOX®) injection.

Timeline

Start date: 2024-10-01
Primary completion: 2026-10-01
Completion: 2026-10-01
First posted: 2024-09-05
Last updated: 2024-09-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06584747. Inclusion in this directory is not an endorsement.